ici 215001 has been researched along with alprenolol in 1 studies
Studies (ici 215001) | Trials (ici 215001) | Recent Studies (post-2010) (ici 215001) | Studies (alprenolol) | Trials (alprenolol) | Recent Studies (post-2010) (alprenolol) |
---|---|---|---|---|---|
8 | 0 | 2 | 1,146 | 121 | 59 |
Protein | Taxonomy | ici 215001 (IC50) | alprenolol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 0.0031 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.007 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.63 | |
Beta-3 adrenergic receptor | Homo sapiens (human) | 0.0023 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0049 | |
Squalene synthase | Rattus norvegicus (Norway rat) | 4.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, JG | 1 |
1 other study(ies) available for ici 215001 and alprenolol
Article | Year |
---|---|
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |